The official results of the French parliamentary elections were announced, and the ruling party coalition held a relatively large number of seats
Li Bin, CEO of Weilai: 800V battery pack will be launched in 2024, which supports power change and ultra fast charging
Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying
The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?
Feb 21, 2022 02:30 PM
Most of the popular Chinese stocks rose before the US market, and the B station rose by more than 7%
Shanghai Municipal Bureau of human resources and social security: international students from the world's top 50 universities can directly settle in Shanghai
2022 China AI Health 30 Report
Us personal consumption expenditure in April increased by 0.9% month on month, with an estimated 0.8%.
Most of the popular Chinese stocks rose before the US stock market, and Weilai rose more than 6%
Andaville: the two shareholders plan to reduce their shares by no more than 4.12% in total
Jincheng pharmaceutical announced that its subsidiary obtained the drug registration certificate of clindamycin phosphate injection.
Tongkun shares: the net profit in the first quarter was 1.503 billion yuan, a year-on-year decrease of 12.45%
Families of non registered residence residents in Nanjing can apply for house purchase after accumulatively paying social security for 6 months within one year
Dongyangguang: it plans to purchase 5.1% equity of Guangyao for 910 million yuan
iQIYI Achieves Steady but Slow Growth with Disciplined Strategies in Q2 2021
China's online entertainment service company iQIYI released its unaudited Q2 2021 financial results on August 12. The revenue growth was rather unimpressive, while the company has been implementing strategies around expanding market presence, diversifying content, and securing a larger user base in light of future growth.
Sep 09, 2021 02:45 AM
Yichang Technology: the net profit in 2021 was 74.3696 million yuan, with a year-on-year increase of 12.95%
Galaxy Securities: the penetration rate of assisted reproduction in China is expected to increase in the future
BGI: the implementation of the actual controller's share increase plan has been completed
Ukrainian defense ministry said that so far, more than 1000 Russian soldiers have been killed in the conflict in Ukraine.
20 Chinese Companies to Watch in Q1 2023 – Technology
Mar 27, 2023 05:43 PM